Emerald Acquisition’s Evolent Health EVH Stock Holding History

Emerald Acquisition’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.18M	Buy	88,392 +20,613	+30%	+$482K	﹤0.01%	1704
2016 Q2	$1.3M	Buy	+67,779	New	+$931K	﹤0.01%	2026

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Emerald Acquisition's EVH Position: Q3 2016 in Review

Emerald Acquisition increased its Evolent Health (EVH) stake by 30% in Q3 2016, buying an estimated $482K and bringing the position to 88,392 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Emerald Acquisition first reported a position in EVH in Q2 2016 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold EVH as of Q3 2016.

Emerald Acquisition held 88,392 shares of Evolent Health worth $2.18M as of Q3 2016.
Emerald Acquisition bought 20,613 Evolent Health shares in Q3 2016, an estimated $482K.
Evolent Health made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1704 holding.
Emerald Acquisition first reported a position in Evolent Health in Q2 2016 and has held it in 2 quarters since.
110 funds tracked by Wall St. Rank held Evolent Health as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.